We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Early Gene Therapy Data Promising for Sickle Cell Anemia

News   Dec 04, 2018 | Original story from Cincinnati Children's Hospital Medical Center

 
Gene Therapy is Reversing Sickle Cell Anemia Symptoms in Preclinical Trials

Technicians work in the ISO-certified cleanroom laboratory at Cincinnati Children’s where gene-correction therapies are tested and produced for clinical trials like the one for sickle cell anemia presented by Punam Malik MD, at this year’s annual meeting of the American Society of Hematology in San Diego. Image credit: Cincinnati Children's Hospital

 
 
 

RELATED ARTICLES

Maturation Process of Natural Killer Cells Mapped

News

Notch signaling is necessary for the normal development and function of natural killer cells. This could be significant for the natural killer cells’ ability to fight cancer and infections.

READ MORE

Precise Engineering of Graphene Could Benefit Lab-on-a-chip Applications

News

A team of NYU researchers has solved a longstanding puzzle of how to build ultra-sensitive, ultra-small electrochemical sensors with homogenous and predictable properties by discovering how to engineer graphene structure on an atomic level.

READ MORE

3D Tracking How a Virus Moves Through a Mosquito

News

Researchers hope to one day inhibit the genes involved with the release of the virus from within the mosquito’s stomach to prevent future transmission of mosquito-borne diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE